EpilepsyepilepsyNCT07090980
Effects of Podcast Education on Medication Perception, Stigma Level, and Epilepsy Self-management in Epilepsy Patients
A study testing epilepsy education via podcast in people with Epilepsy and Stigma, run by Istanbul Sabahattin Zaim University at 1 site in Turkey (Türkiye).
Trial summary
Seventy epilepsy patients who presented to Gaziosmanpaşa Training and Research Hospital as outpatients (diagnosed at least 3 months prior, taking at least one medication, and having access to the internet) were randomly assigned to two groups. Read more about this study
- Who is it for?
- Ages 18 to 65 years
- Conditions the study is for
- Epilepsy, Stigma, Self Management
- What is being tested?
- epilepsy education via podcast
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 70 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 25 Nov 2024to 17 May 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Volunteer to participate in the study
- 18 years of age
- Diagnosed with epilepsy at least 3 months ago
- Taking at least one antiepileptic drug
Who cannot join
- Being diagnosed with mental retardation
- Having language and communication barriers
- Not having sufficient equipment
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
Gaziosmanpaşa Eğitim ve Araştırma Hastanesi
Istanbul, gaziosmanpaşa, 34100
About this study
Official title: Effects of Podcast Education on Medication Perception, Stigma Level, and Epilepsy Self-management in Epilepsy Patients.
Seventy epilepsy patients who presented to Gaziosmanpaşa Training and Research Hospital as outpatients (diagnosed at least 3 months prior, taking at least one medication, and having access to the internet) were randomly assigned to two groups. 35 patients were assigned to the experimental group, and 35 patients to the control group. All patients were asked to complete a sociodemographic form, self-management form, medication adherence form, and stigma form as pre-tests. The experimental group was exposed to an epilepsy education podcast recorded by the researcher via Spotify. The control group received routine outpatient education provided by the doctor. The same tests were repeated at 1 and 3 months, and the effectiveness of the education was evaluated. Differences between the two groups and changes over time were monitored.
- Conditions
- Epilepsy, Stigma, Self Management, Drug Therapy
- Being tested
- epilepsy education via podcast
- Keywords
- Epilepsy, podcast, nursing, stigma, self-management, drug perception
- Medical subject headings
- Epilepsy, Social Stigma
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
epilepsy education via podcastOther
Epilepsy education via podcast has never been provided in any clinical study in Turkey before. By providing education via podcast, we have made health education more accessible and repeatable.
| Study group | Role | What they receive |
|---|---|---|
| experimental group | Experimental | This group was played a podcast containing information about epilepsy Receives: Other: epilepsy education via podcast |
| control group | No intervention | This group received routine outpatient information about epilepsy from their doctor. No additional intervention is required. |
What is being measured
The primary outcome is the main question the study is designed to answer.
first month results
Members of the intervention and control groups were assessed at the initial meeting using four forms listed by the researchers: the "Patient Information Form," the "Medication Beliefs Questionnaire," the "Feeled Stigma Scale," and the "Self-Management Scale." The control group received routine outpatient clinic education, while the patient group, designated as the intervention group, received education via a six-part podcast containing information about the epilepsy system for approximately 25 people. At the end of the training, both groups were assessed using the same four forms at the end of the first and third months.
Measured: 1 month result
Secondary outcomes (1)
third month result
Members of the intervention and control groups were assessed at the initial meeting using four forms listed by the researchers: the "Patient Information Form," the "Medication Beliefs Questionnaire," the "Feeled Stigma Scale," and the "Self-Management Scale." The control group received routine outpatient clinic education, while the patient group, designated as the intervention group, received education via a six-part podcast containing information about the epilepsy system for approximately 25 people. At the end of the training, both groups were assessed using the same four forms at the end of the first and third months.
Measured: three months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted29 Jul 2025
- Study start25 Nov 2024
- Primary completion15 May 2025
- Study completion17 May 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for EpilepsyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Two groups were randomly assigned as the experimental and control groups.
- Masking
- None (open label)
- Enrolment
- 70 participants (actual)
Sponsor and investigators
- Lead sponsor
- Istanbul Sabahattin Zaim University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Gökçe Çiçek Yavaş, Istanbul Sabahattin Zaim University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07090980
- Sponsor's protocol ID
- 07/2023
- Acronym
- epilepsy
- Status last verified
- Jul 2025
- First submitted
- 15 Jun 2025
- Last updated
- 29 Jul 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Personal data will not be shared for the purpose of protecting personal data.
Study at a glance
From the registry record, last updated by the sponsor on 29 Jul 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effects of Podcast Education on Medication Perception, Stigma Level, and Epilepsy Self-management in Epilepsy Patients.
- ClinicalTrials.gov ID
- NCT07090980
- Acronym / sponsor ID
- epilepsy / 07/2023
- Conditions
- Epilepsy, Stigma, Self Management, Drug Therapy
- Keywords
- Epilepsy, podcast, nursing, stigma, self-management, drug perception
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 70 participants (actual)
- Lead sponsor
- Istanbul Sabahattin Zaim UniversityUniversity, hospital or other
- Study start
- 25 Nov 2024 (actual)
- Primary completion
- 15 May 2025 (actual)
- Study completion
- 17 May 2025 (actual)
- First posted
- 29 Jul 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Seventy epilepsy patients who presented to Gaziosmanpaşa Training and Research Hospital as outpatients (diagnosed at least 3 months prior, taking at least one medication, and having access to the internet) were randomly assigned to two groups. 35 patients were assigned to the experimental group, and 35 patients to the control group. All patients were asked to complete a sociodemographic form, self-management form, medication adherence form, and stigma form as pre-tests. The experimental group was exposed to an epilepsy education podcast recorded by the researcher via Spotify. The control group received routine outpatient education provided by the doctor. The same tests were repeated at 1 and 3 months, and the effectiveness of the education was evaluated. Differences between the two groups and changes over time were monitored.
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- Two groups were randomly assigned as the experimental and control groups.
| Arm | Type | Receives |
|---|---|---|
| experimental group | Experimental | Other: epilepsy education via podcastThis group was played a podcast containing information about epilepsy |
| control group | No intervention | –This group received routine outpatient information about epilepsy from their doctor. No additional intervention is required. |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Volunteer to participate in the study
- 18 years of age
- Diagnosed with epilepsy at least 3 months ago
- Taking at least one antiepileptic drug
Key exclusion criteria (3 listed)
- Being diagnosed with mental retardation
- Having language and communication barriers
- Not having sufficient equipment
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| epilepsy education via podcastEpilepsy education via podcast has never been provided in any clinical study in Turkey before. By providing education via podcast, we have made health education more accessible and repeatable. | Other | experimental group |
Primary outcome
first month results
Time frame: 1 month result
Members of the intervention and control groups were assessed at the initial meeting using four forms listed by the researchers: the "Patient Information Form," the "Medication Beliefs Questionnaire," the "Feeled Stigma Scale," and the "Self-Management Scale." The control group received routine outpatient clinic education, while the patient group, designated as the intervention group, received education via a six-part podcast containing information about the epilepsy system for approximately 25 people. At the end of the training, both groups were assessed using the same four forms at the end of the first and third months.
1 secondary outcome
third month result
Time frame: three months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 29 Jul 2025.
- Individual participant dataSharing planned: No. Personal data will not be shared for the purpose of protecting personal data.
Related trials for Epilepsy
Not yet recruiting
Clinical Trial of SEEG for Drug-resistant Epilepsy
Drug-Resistant Epilepsy
RecruitingPhase 3
Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
Seizures, Lennox Gastaut Syndrome
RecruitingPhase 3
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures
Focal Seizure, Epilepsy
Active, not recruitingObservational study
Transforming Research and Clinical Knowledge in Traumatic Brain Injury Epileptogenesis Project (TRACK-TBI EPI)
Traumatic Brain Injury, Post-traumatic Epilepsy
RecruitingPhase 3
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1
Focal Seizure, Epilepsy
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing epilepsy education via podcast in people with Epilepsy and Stigma, run by Istanbul Sabahattin Zaim University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 29 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
first month results (time frame: 1 month result). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Jul 2025.